In her presentation, Dr. Barbakadze shared findings from her recent clinical research focused on the role of Endometrial Receptivity Analysis (ERA) in enhancing IVF outcomes.
Key insights from the presentation:
- ERA-guided personalized embryo transfer significantly increases implantation and live birth rates
- IVF outcomes in advanced age patients became comparable to those under 35
- The effect was especially strong in cycles using PGT-A tested embryos
This international recognition highlights Reproart’s ongoing contribution to evidence-based reproductive medicine and our commitment to innovation and excellence in patient care.
We’re honored to see Georgian clinical research featured on the global stage.
